Financial statements Biomaxima
Balance sheet data of BIOMAXIMA
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 42 996 569,99 | 43 244 615,95 | 53 186 155,58 |
| A. Fixed assets | 26 387 029,86 | 25 471 423,10 | 26 001 791,38 |
| B. Current assets | 16 609 540,13 | 17 773 192,85 | 27 184 364,20 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 |
| Total liabilities | 42 996 569,99 | 43 244 615,95 | 53 186 155,58 |
| A. Equity | 16 926 501,32 | 16 857 372,39 | 26 647 652,66 |
| B. Liabilities and provisions for liabilities | 26 070 068,67 | 26 387 243,56 | 26 538 502,92 |
| I. Long-term liabilities | 7 381 888,08 | 6 375 094,34 | 7 374 687,14 |
| II. Short-term liabilities | 14 285 282,79 | 11 595 885,96 | 11 117 381,35 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.